DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $32.67.

A number of research analysts have commented on the company. Stifel Nicolaus reduced their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Barrington Research restated an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Finally, Evercore ISI reduced their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of XRAY. Oak Thistle LLC acquired a new position in DENTSPLY SIRONA during the first quarter valued at $216,000. Mirae Asset Global Investments Co. Ltd. grew its stake in DENTSPLY SIRONA by 8.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier’s stock valued at $1,328,000 after purchasing an additional 3,219 shares in the last quarter. BNP Paribas Financial Markets grew its stake in DENTSPLY SIRONA by 117.1% in the first quarter. BNP Paribas Financial Markets now owns 406,242 shares of the medical instruments supplier’s stock valued at $13,483,000 after purchasing an additional 219,108 shares in the last quarter. Nordea Investment Management AB grew its stake in DENTSPLY SIRONA by 6.7% in the first quarter. Nordea Investment Management AB now owns 83,898 shares of the medical instruments supplier’s stock valued at $2,784,000 after purchasing an additional 5,288 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in DENTSPLY SIRONA by 7.9% in the first quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after purchasing an additional 1,296 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $23.31 on Friday. DENTSPLY SIRONA has a fifty-two week low of $22.85 and a fifty-two week high of $37.60. The business has a 50 day moving average price of $25.22 and a two-hundred day moving average price of $26.47. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The firm has a market cap of $4.73 billion, a PE ratio of -27.10, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter last year, the business earned $0.51 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% compared to the same quarter last year. Sell-side analysts expect that DENTSPLY SIRONA will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.75%. The ex-dividend date of this dividend was Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -74.42%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.